Details

Autor(en) / Beteiligte

• Baumann, S
• Becher, T
• Giannakopoulos, K
• Jabbour, C
• Fastner, C
• El-Battrawy, I
• Ansari, U
• Lossnitzer, D
• Behnes, M
• Alonso, A
• Kirschning, T
• Dissmann, R
• Kueck, O
• Stern, D
• Michels, G
• Borggrefe, M
• Akin, I

Titel

Bedside implantation of a new temporary vena cava inferior filter : German results from the European ANGEL registry

Ist Teil von

• Medizinische Klinik, Intensivmedizin und Notfallmedizin, 2018-04, Vol.113 (3), p.184-191

Ort / Verlag

Germany

Erscheinungsjahr

2018

Quelle

MEDLINE

Beschreibungen/Notizen

• Pulmonary embolism (PE) is a frequently occurring complication in critically ill patients, and the simultaneous occurrence of PE and life-threatening bleeding is a therapeutic dilemma. Inferior vena cava filters (IVCF) may represent an important therapeutic alternative in these cases. The Angel® catheter (Bio2 Medical Inc., San Antonio, TX, USA) is a novel IVCF that provides temporary protection from PE and is implanted at bedside without fluoroscopy. The European Angel® Catheter Registry is an observational, multicenter study. In our German substudy, we investigated patients from three German hospitals and four intensive care units, who underwent Angel® catheter implantation between February 2016 and December 2016. A total of 23 critically ill patients (68 ± 9 years, 43% male) were included. The main indication for implantation was a high risk for or an established PE, combined with contraindications for prophylactic or therapeutic anticoagulation due to either an increased risk of bleeding (81%) or active bleeding (13%). The Angel® catheter was successfully inserted in all patients at bedside. No PE occurred in patients with an indwelling Angel® catheter. Clots with a diameter larger the 20 mm, indicating clot migration, were detected in 5% of the patients by cavography before filter retrieval. Filter retrieval was uneventful in all of our cases, while filter dislocation occurred in 3% of the patients. The German data from the multicenter European Angel® Catheter Registry show that the Angel® catheter is a safe and effective approach for critically ill patients with a high risk for the development of PE or an established PE, when an anticoagulation therapy is contraindicated.